Norflurane
Highest phase reached
Phase 2
Drug type
Small molecule
- Listing at source
- Listed
- Highest phase reached
- Phase 2
- Drug type
- Small molecule
- Drug name
- Norflurane
- Molecular weight
- 102.03
- Structure (SMILES)
- FCC(F)(F)F
- dymel 134a
- Dymel 134a
- forane 134a
- Forane 134a
- freon 134a
- Freon 134a
- genetron 134a
- Genetron 134a
- hfa 134 a
- hfa 134a
- HFA 134A
- hfa 134a propellant
- HFA-134-A
- Hfa-134a
- HFA-134A propellant
- HFA-134A PROPELLANT
- hfc 134a
- hfc 134a mi
- HFC-134A
- HFC-134A [MI]
- hydrofluorocarbon 134a
- Hydrofluorocarbon 134a
- norflurane
- Norflurane
- NORFLURANE [EP MONOGRAPH]
And 25 more, listed on the interactive page.
- CAS registry numbers
- 811-97-2
- ChEMBL ID
- CHEMBL2104432
- InChIKey
- LVGUZGTVOIAKKC-UHFFFAOYSA-N
- PubChem compound IDs
- 13129
- RxNorm IDs (RxCUI)
- 1311560
- FDA ingredient codes (UNII)
- DH9E53K1Y8
- First in class
- No
- Orphan designation
- No
- Drug name stem
- -flurane
- Hydrogen bond acceptors
- 0
- Hydrogen bond donors
- 0
- Polar surface area
- 0
- Calculated partition coefficient (ALogP)
- 1.52
- Calculated partition coefficient (XLogP)
- 1.7
- Prodrug
- No
- Chirality
- Achiral
- Inorganic
- No
- Rule-of-five violations
- 0
- Rotatable bonds
- 0
- Heavy atoms
- 6
- Molecular formula
- C2H2F4
- Monoisotopic mass
- 102.00926271
- Natural product
- No
- Recorded assays
- 34
- Active assays
- 3
Active assay types
- Other
- Aerosol Propellants
- Anesthetics
Related records
Trials (5)
- A Study to Assess the Potential for Airway Sensitivity Reactions With Propellants HFA-152a (Test) and HFA-134a (Reference) Administered Via Pressurized Inhalers in Adults With Mild Asthma
- A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
- Comparison Between CHF5993 pMDI 200/6/12.5 µg HFA-152a VS CHF5993 pMDI 200/6/12.5 µg HFA-134a in Subjects With Asthma (TRECOS).
- Study to Assess Effect of Next-Generation Propellant MDI on Mucociliary Clearance Vs. HFA Propellant MDI in Healthy Participants
- Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma